- Home
- PYPD vs TRT Comparison
PYPD vs TRT Comparison
Compare PYPD & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- TRT
- Stock Information
- Founded
- PYPD 2008
- TRT 1958
- Country
- PYPD Israel
- TRT United States
- Employees
- PYPD N/A
- TRT N/A
- Industry
- PYPD Medical/Dental Instruments
- TRT Industrial Machinery/Components
- Sector
- PYPD Health Care
- TRT Technology
- Exchange
- PYPD Nasdaq
- TRT Nasdaq
- Market Cap
- PYPD 26.7M
- TRT 22.5M
- IPO Year
- PYPD 2020
- TRT N/A
- Fundamental
- Price
- PYPD $2.90
- TRT $4.86
- Analyst Decision
- PYPD Strong Buy
- TRT
- Analyst Count
- PYPD 2
- TRT 0
- Target Price
- PYPD $10.50
- TRT N/A
- AVG Volume (30 Days)
- PYPD 19.1K
- TRT 5.0K
- Earning Date
- PYPD 05-14-2025
- TRT 05-13-2025
- Dividend Yield
- PYPD N/A
- TRT N/A
- EPS Growth
- PYPD N/A
- TRT N/A
- EPS
- PYPD N/A
- TRT 0.00
- Revenue
- PYPD N/A
- TRT $35,548,000.00
- Revenue This Year
- PYPD N/A
- TRT N/A
- Revenue Next Year
- PYPD N/A
- TRT N/A
- P/E Ratio
- PYPD N/A
- TRT $1,112.34
- Revenue Growth
- PYPD N/A
- TRT N/A
- 52 Week Low
- PYPD $2.30
- TRT $4.85
- 52 Week High
- PYPD $4.75
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- PYPD 56.83
- TRT 38.01
- Support Level
- PYPD $2.71
- TRT $5.10
- Resistance Level
- PYPD $2.89
- TRT $5.69
- Average True Range (ATR)
- PYPD 0.19
- TRT 0.21
- MACD
- PYPD 0.02
- TRT 0.02
- Stochastic Oscillator
- PYPD 56.25
- TRT 0.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.